CompletedNot Applicable

Thyroid Lobectomy With or Without Levothyroxine Treatment Postoperatively

Poland150 participantsStarted 2000-01

Plain-language summary

The aim of this study was to compare the prevalence of recurrent nodular goiter in the contralateral thyroid lobe among patients after unilateral thyroid lobectomy for unilateral multinodular goiter receiving versus not receiving prophylactic levothyroxine treatment postoperatively in a five-year follow-up of a randomized study

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * unilateral multinodular goiter with normal appearing on ultrasound of the neck contralateral thyroid lobe, in a patient in euthyroid state Exclusion Criteria: * bilateral multinodular goiter, enlargement of contralateral thyroid lobe (volume on ultrasound \>10 ml), suspicion of thyroid cancer, previous thyroid surgery, thyroiditis, subclinical or clinically overt hypothyroidism or hyperthyroidism, pregnancy or lactation, age \< 18 years or \> 65 years, ASA 4 grade (American Society of Anesthesiology), and inability to comply with the follow-up protocol

What they're measuring

Primary outcome measure was prevalence of recurrent goiter within the contralateral thyroid lobe

Timeframe: at 3, 6, 9, 12, 24, 36, 48 and 60 months postoperatively

Trial details

NCT IDNCT00941551

SponsorJagiellonian University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2003-12

View on ClinicalTrials.gov More Recurrent Goiter trials